Experimental immunotherapies for multiple sclerosis

Springer Seminars in Immunopathology

Volumn 18, Issue 1, 1996, Pages 1-24

  Martin, Roland ^a,b   McFarland, Henry ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; BETA INTERFERON; CD4 ANTIGEN; CLADRIBINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; LYMPHOTOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; METHOTREXATE; MITOXANTRONE; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; AUTOIMMUNITY; CELL ADHESION; CLONAL ANERGY; DEMYELINATING DISEASE; DRUG EFFECT; DRUG THERAPY; ETIOLOGY; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; WHOLE BODY RADIATION;

HUMANS; IMMUNOTHERAPY; MULTIPLE SCLEROSIS;

EID: 0030014629     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00792605     Document Type: Review

References (163)

1. Acha-Orbea H, Mitchell L, Timmermann L, Wraith DC, Tausch GS, Waldor KM, Zamvil SS, McDevitt HO, Steinman L (1988) Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54:263
2. Achiron A, Margalit R, Hershkoviz R, Markovits D, Reshef T, Melamed E, Cohen IR, Lider O (1944) Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor α secretion. J Clin Invest 93:600
3. Aharoni R, Teitelbaum D, Arnon R, Puri J (1991) Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen-Ia complex. Nature 351:147
4. Al-Sabbagh A, Miller A, Santos LMB, Weiner HL (1994) Antigen-driven tissue-specific suppression following oral tolerance: orally admistered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse. Eur J Immunol 24:2104
5. Amor S, Groome N, Linington C, Morris MM, Dornmair K, Gardinier MV, Matthieu J-M, Baker D (1994) Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 153:4349
6. Ando DG, Clayton J, Kono D, Urban JL, Sercarz EE (1989) Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol 124:132
7. Archelos JJ, Jung S, Mäurer M, Schmied M, Lassmann H, Tamatami T, Miyasaka M, Toyka KV, Hartung H-P (1993) Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Ann Neurol 34:145
8. Baker D, Butler D, Scallon BJ, O'Neill JK, Turk JL, Feldmann M (1994) Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur J Immunol 24:2040
9. Baron JL, Madri JA, Ruddle NH, Hashim G, Janeway CA (1993) Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 177:57
10. Bell RB, Lindsey JW, Sobel RA, Hodgkinson S, Steinman L (1993) Diverse T cell receptor Vβ gene usage in the central nervous system in experimental allergic encephalomyelitis. J Immunol 150:4085
11. Ben Nun A, Wekerle H, Cohen IR (1981) Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature 293:60
12. Bitar DM, Whitacre CC (1988) Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell Immunol 112:364
13. Boggs JM, Chang NH, Goundalkar A, Hashim GA (1992) Stimulation or tolerization of an anti-myelin basic protein T lymphocyte line with membrane fragments from antigen presenting cells. Cell Immunol 143:23
14. Bourdette DN, Whitham RH, Chou YK, Morrison WJ, Atherton J, Kenny C, Liefeld D, Hashim GA, Offner H, Vandenbark AA (1994) Immunity to TCR peptides in multiple sclerosis. I. Successful immunization of patients with synthetic Vβ5.2 and Vβ6.1 CDR2 peptides. J Immunol 152:2510
15. Brocke S, Gaur, A, Piercy C, Gautam A, Gijbels K, Fathman CG, Steinman L. (1993) Induction of relapsing paralysis in experimental allergic encephalomyelitis by bacterial superantigen. Nature 365:642
16. Broome Powell M, Mitchell D, Lederman J, Buckmeier J, Zamvil SS, Graham M, Ruddle N, Steinman L (1990) Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int Immunol 2:539
17. Brostoff SW, Mason DW (1984) Experimental allergic encephalomyelitis: Successful treatment in vivo with a monoclonal antibody that recognizes T helper cells. J Immunol 133:1938
18. Buenafe AC, Vainiene M, Celnik B, Vandenbark AA, Offner H (1994) Analysis of Vβ8-CDR3 sequences derived from central nervous system of Lewis rats with experimental autoimmune encephalomyelitis. J Immunol 153:386
19. Burns FR, Li X, Shen N, Offner H, Chou YK, A. V, Heber-Katz A (1989) Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar Vα and Vβ chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different. J Exp Med 169:27
20. Burns J, Rosenzweig A, Zweiman B, Lisak RP (1983) Isolation of myelin basic protein-reactive T-cell lines from normal human blood. Cell Immunol 81:435
21. Cannella B, Cross AH, Raine CS (1990) Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system. J Exp Med 172:1521
22. Cannella B, Cross AH, Raine CS (1993) Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitis. J Neuroimmunol 46:43
23. Cash E, Minty A, Ferrara P, Caput D, Fradelizi D, Rott O (1994) Macrophage inactivation IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J Immunol 153:4258
24. Chen Y, Kuchroo VK, Inobe J-I, Hafler DA, Weiner HL (1994) Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237
25. Chluba J, Steeg C, Becker A, Wekerle H, Epplen JT (1989) T cell receptor β chain usage in myelin basic protein-specific rat T lymphocytes. Eur J Immunol 19:279
26. Chofflon M, Juillard C, Juillard P, Gauthier G, Grau GE (1992) Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis. Eur Cytokine Netw 3:523
27. Chou YK, Morrison WJ, Weinberg AD, Dedrick R, Whitham R, Bourdette DN, Hashim G, Offner H, Vandenbark AA (1994) Immunity to TCR peptides in multiple sclerosis. II. T cell recognition of Vβ5.2 and Vβ6.1 CDR2 peptides. J. Immunol 152:2520
28. Clayton JP, Gammon GM, Ando DG, Kono DH, Hood L, Sercarz EE (1989) Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein. J Exp Med 169:1681
29. Critchfield JM, Racke MK, Zuniga-Pflücker JC, Cannella B, Raine CS, Goverman J, Lenardo MJ (1994) T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 263:1139
30. Cross AH, Cannella B, Brosnan CF, Raine CS (1990) Homing to central nervous system vasculature by antigen specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic and relapsing experimental allergic encephalomyelitis. Lab Invest 63:162
31. Cross AH, O'Mara T, Raine CS (1993) Chronologic localization of myelin-reactive cells in the lesions of relapsing EAE: implications for the study of multiple sclerosis. Neurology 43:1028
32. Cross AH, Misko TP, Lin RF, Hickey WF, Trotter JL, Tilton RG (1994) Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J Clin Invest 93:2684
33. De Magistris MT, Alexander J, Coggeshall M, Altman A, Gaeta FCA, Grey HM, Sette A (1992) Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 68:625
34. Dopp JM, Breneman SM, Olschowska JA (1994) Expression of ICAM-1, VCAM-1, L-selectin, and leukosialin in the mouse central nervous system during the induction and remission of experimental allergic encephalomyelitis. J Neuroimmunol 54:129
35. Evavold BD, Sloan-Lancaster J, Allen PM (1993) Tickling the TCR: selective T cell functions stimulated by altered peptide ligands. Immunol Today 14:602
36. Fritz RB, McFarlin DE (1989) Encephalitogenic epitopes of myelin basic protein. Chem Immunol 46:101
37. Fritz RB, Skeen MJ, Jen-Chou CH, Garcia M, Egorov IK (1985) Major histocompatibility complex-linked control of the murine immune response to myelin basic protein. J Immunol 134:2328
38. Gaur A, Wiers B, Liu A, Rothbard J, Fathman CG (1992) Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 258:1491
39. + cells in T cell receptor peptide-induced clonal unresponsiveness. Science 259:91
40. Genain CP, Lee-Parritz D, Nguyen M-H, Massacesi L, Joshi N, Ferrante R, Hoffman K, Moseley M, Letvin NL, Hauser SL (1994) In healthy primates, circulating autoreactive T cells mediate autoimmune disease. J Clin Invest 94:1339
41. Genain CP, Nguyen MH, Faulds D, Uccelli A, Davis RL, Hedgpeth J, Hauser SL (1994) Prevention of EAE in non-human primates by a type IV phosphodiesterase inhibitor that suppresses tumor necrosis factor. J Neuroimmunol 54:163
42. Giegerich G, Pette M, Meinl E, Epplen JT, Wekerle H, Hinkkanen A (1992) Diversity of T cell receptor alpha and beta chain genes expressed by human T cells specific for similar myelin basic protein peptide/major histocompatibility complexes. Eur J Immunol 22:753
43. Gijbels K, Galardy RE, Steinman L (1994) Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J Clin Invest 94:2177
44. Goss JA, Nakafusa Y, Roland CR, Hickey WF, Flye M (1994) Immunological tolerance to a defined myelin basic protein antigen administered intrathymically. J Immunol 153:3890
45. Gregerson DS, Obritsch WF, Donoso LA (1993) Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. J Immunol 151:5751
46. Harris JO, Frank JO, Patronas N, McFarlin DE, McFarland HF (1991) Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: Implication for clinical trials and natural history. Ann Neurol 29:548
47. Hickey WF, Hsu BL, Kimura H (1991) T-lymphocyte entry into the central nervous system. J Neurosci. Res 28:254
48. Howell MD, Winters ST, Olee T, Powell HC, Carlo DJ, Brostoff SW (1989) Vaccination against experimental allergic autoimmune encephalomyelitis with T cell receptor peptides. Science 246:668
49. Ishioka GY, Adorini L, Guery J-C, Gaeta FCA, LaFond R, Alexander J, Powell MF, Sette A, Grey HM (1994) Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. J Immunol 152:4310
50. Jacobs CA, Baker PE, Roux ER, Picha KS, Toivola B, Waugh S, Kennedy MK (1991) Experimental autoimmune encephalomyelitis is exacerbated by IL-1α and suppressed by soluble IL-1 receptors. J Immunol 146:2983
51. Jameson BA, McDonnell JM, Marini JC, Korngold R (1994) A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis. Nature 368:744
52. Johns LD, Flanders KC, Ranges GE, Sriram S (1991) Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1. J Immunol 147:1792
53. Jorgensen JL, Esser U, Fazekas de St. Groth B, Reay PA, Davis MM (1992) Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature 355:224
54. Karin N, Szafer F, Mitchell D, Gold DP, Steinman L (1993) Selective and nonselective stages in homing of T lymphocytes to central nervous system during experimental allergic encephalomyelitis. J Immunol 150:4116
55. Karin N, Mitchell DJ, Brocke S, Ling N, Steinman L (1994) Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon γ and tumor necrosis factor α production. J Exp Med 180:2227
56. Kawano Y-I, Sasamoto Y, Kotake S, Thurau SR, Wiggert B, Gery I (1991) Trials of vaccination against experimental autoimmune uveoretinitis with a T-cell receptor peptide. Curr Eye Res 10:789
57. Kennedy MK, L.-J T, Dal Canto MC, Tuohy VK, Lu Z, Trotter JL, Miller SD (1990) Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides. J Immunol 144:909
58. Kennedy MK, Tan L-J, Dal Canto MC, Miller SD (1990) Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. J Immunol 145:117
59. Kennedey MK, Torrance DS, Picha KS, Mohler KM (1992) Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 149:2496
60. Kojima K, Berger T, Lassmann H, Hinze-Selch D, Zhang Y, Gehrmann J, Reske K, Wekerle H, Linington C (1994) Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100β molecule, a calcium binding protein of astroglia. J Exp Med 180:817
61. Kotzin BL, Karuturi S, Chou YK, Lafferty J, Forrester M, Better M, Nedwin GE, Offner H, Vandenbark A (1991) Preferential T-cell receptor Vβ-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. Proc Natl Acad Sci USA 88:9161
62. Kuchroo VK, Martin CA, Greer JM, Ju S-T, Sobel RA, Dorf ME (1993) Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J Immunol 151:4371
63. Kuchroo VK, Greer JM, Kaul D, Ishioka G, Franco A, Sette A, Sobel RA, Lees MB (1994) A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire. J Immunol 153:3326
64. Kuhröber A, Schirmbeck R, Reimann J (1994) Vaccination with T cell receptor peptides primes anti-receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL. Eur J Immunol 24:1172
65. + T cells in recovery from antigen-induced autoimmune disease. J Exp Med 178:909
66. Kuruvilla AP, Shah R, Hochwald GM, Liggitt HD, Palladino MA, Thorbecke GJ (1991) Protective effect of transforming growth factor β1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci USA 88:2918
67. Lafaille JJ, Nagashima K, Katsuki M, Tonegawa S (1994) High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 78:399
68. Lamont AG, Sette A, Fujinami R, Colon SM, Miles C, Grey HM (1990) Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for IAs molecules. J Immunol 145:1687
69. Lee SC, Dickson DW, Liu W, Brosnan CF (1993) Induction of nitric oxide synthase activity in human astrocytes by interleukin-1β and interferon-γ. J Neuroimmunol 46:19
70. Leonard JP, Waldburger KE, Goldman SJ (1995) Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J Exp Med 181:381
71. Liebert UG, Hashim GA, ter Meulen V (1990) Characterization of measles virus-induced cellular autoimmune reactions against myelin basic protein in Lewis rats. J Neuroimmunol 29:139
72. Lindsey JW, Hodgkinson S, Mehta R, Mitchell D, Enzmann D, Steinman L (1994) Repeated treatment with chimeric anti-CD4 antibody in multiple sclerosis. Ann Neurol 36:183
73. Linington C, Bradl M, Lassmann H, Brunner C, Vass K (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 130:443
74. Lipton HL, Dal Canto MC (1976) Theiler's virus-induced demyelination - prevention by immunosuppression. Science 192:62
75. Lohse AW, Mor F, Karin N, Cohen IR (1989) Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells. Science 244:820
76. Martin R, Jaraquemada D, Flerlage M, Richert J, Whitaker J, Long FO, McFarlin DE, McFarland HF (1990) Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J Immunol 145:540
77. Martin R, McFarland HF, McFarlin DE (1992) Immunological aspects of demyelinating diseases. Annu Rev Immunol 10:153
78. + cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J Immunol 148:1359
79. Massacesi L, Castigli E, Vergelli M, Olivotto J, Abbamondi AL, Sarlo F, Amaducci L (1991) Immunosuppressive activity of 13-cis-retinoic acid and prevention of experimental autoimmune encephalomyelitis in rats. J Clin Invest 88:1331
80. McCarron RM, Spatz M, Kempski O, Hogan RN, Muehl L, McFarlin DE (1986) Interaction between myelin basic protein-sensitized T lymphocytes and murine cerebral vascular endothelial cells. J Immunol 137:3428
81. McCarron RM, Tanaka M, Spatz M (1990) Class II major histocompatibility complex antigen expression in central nervous system: microglia, astrocytes and endothelial cells. In: Pathophysiology of the blood-brain barrier. Johansson BB, Owman CO, Widmer H (eds), Elsevier, Amsterdam, pp467-484
82. McCarron RM, Wang L, Racke MK, McFarlin DE, Spatz M (1993) Cytokine-regulated adhesion between encephalitogenic T lymphocytes and ccrebrovascular endothelial cells. J Neuroimmunol 43:23
83. McFarland HF, Frank JA, Albert PS, Smith ME, Martin R, Harris JO, Patronas N, Maloni H, McFarlin DE (1992) Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol 32:758
84. Metzler B, Wraith DC (1993) Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int Immunol 5:1159
85. Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL (1992) Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci USA 89:421
86. Moscarello MA, Wood DD, Ackerley C, Boulias C (1994) Myelin in multiple sclerosis is developmentally immature. J Clin Invest 94:146
87. Mustafa M, Vingsbo C, Olsson T, Ljungdahl Å, Höjeberg B, Holmdahl R (1993) The major histocompatibility complex influences myelin basic protein 63-88-induced T cell cytokine profile and experimental autoimmune encephalomyelitis. Eur J Immunol 23:3089
88. Nataf S, Louboutin JP, Chabannes D, Feve JR, Muller JY (1993) Pentoxifylline inhibits experimental allergic encephalomyelitis. Acta Neurol. Scand 88:97
89. Offner H, Hashim GA, Vandenbark AA (1991) T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science 251:430
90. Oksenberg JR, Panzara MA, Begovich AB, Mitchell D, Erlich HA, Murray RS, Shimonkevitz R, Sherritt M, Rothbard J, Bernard CCA, Steinman L (1993) Selection for T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 362:68
91. Olsson T, Sun J, Hillert J, Hojeberg B, Ekre HP, Andersson G, Olerup O, Link H (1992) Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis. Eur J Immunol 22:1083
92. Olsson T, Wei Zhi W, Hojeberg B, Kostulas V, Yu-Ping J, Anderson G, Ekre HP, Link H (1990) Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-γ. J Clin Invest 86:981
93. O'Neill JK, Butter C, Baker D, Gschmeissner SE, Kraal G, Butcher EC (1991) Expression of vascular addressins and ICAM-1 by endothelial cells in the spinal cord during chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. Immunology 72:520
94. Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA (1990) T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346:183
95. Owhashi M, Heber-Katz E (1989) Protection from experimental allergic encephalomyelitis conferred by a monoclonal antibody directed against a shared idiotype on rat T cell receptors specific for myelin basic protein. J Exp Med 168:2153
96. Panitch HS, Hirsch RL, Schindler J, Johnson KP (1987) Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 37:1097
97. Paty DW, Li DKB, the UBC MS/MRI Study Group and the JFNB MS Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter. randomized, double-blind, placebo-controlled trial. Neurology 43:662
98. Pette M, Fujita K, Kitze B, Whitaker JN, Albert E, Kappos L, Wekerle H (1990) Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology 40:1770
99. - T lymphocytes. J Immunol 127:1420
100. Prineas JW (1985) The neuropathology of multiple sclerosis. Handb Clin Neurol 47:213
101. Racke MK, Dhib-Jalbut S, Cannella B, Albert PS, Raine CS, McFarlin DE (1991) Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1. J Immunol 146:3012
102. Racke MK, Cannella B, Albert P, Sporn M, Raine CS, McFarlin DE (1992a) Evidence of endogenous regulatory function of transforming growth factor-β1 in experimental allergic encephalomyelitis. Int Immunol 4:615
103. Racke MK, Martin R, McFarland HF, Fritz RB (1992) Copolymer-1-induced inhibition of antigen-specific T cell activation: interference with antigen presentation. J Neuroimmunol 37:75
104. Racke MK, Sriram S, Carlino J, Cannella B, Raine CS, McFarlin DE (1993) Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β2. J Neuroimmunol 46:175
105. Racke MK, Bonomo A, Scott DE, Cannella B, Levine A, Raine CS, Shevach EM, Röcken M (1994a) Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 180:1961
106. Racke MK, Quigley L, Cannella B, Raine CS, McFarlin DE, Scott DE (1994) Superantigen modulation of experimental allergic encephalomyelitis: activation or anergy determines outcome. J Immunol 152:2051
107. Racke MK, Burnett D, Pak S-H, Albert PS, Cannella B, Raine CS, McFarlin DE, Scott DE. (1995) Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol 154:450
108. Raine CS (1983) Multiple sclerosis and chronic relapsing EAE: comparative ultrastructural neuropathology. In: Hallpike JF, Adams CW, Tourtelotte WW (eds) Multiple sclerosis. Williams & Wilkins, Baltimore, pp 413-178
109. Raine CS, Scheinberg LC (1988) On the immunopathology of plaque development and repair in multiple sclerosis. J Neuroimmunol 20:189
110. Raine CS, Cannella B, Duijvestijn AM, Cross AH (1990) Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination. Lab Invest 63:476
111. Renno T, Krakowski M, Piccirillo C, Lin J, Owens T (1995) TNF-α expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental encephalomyelitis. J Immunol 154:944
112. Richert JR, Robinson ED, Deibler GE, Martenson RE, Dragovic LJ, Kies MW (1989) Human cytotoxic T-cell recognition of a synthetic peptide of myelin basic protein. Ann Neurol 26:342
113. Rott O, Wekerle H, Fleischer B (1992) Protection from experimental allergic encephalomyelitis by application of a bacterial superantigen. Int Immunol 4:347
114. Rott O, Cash E, Fleischer B (1993) Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type1- but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats. Eur J Immunol 23:1745
115. Rott O, Fleischer B, Cash E (1994) Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol 24:1434
116. Ruddle NH, Bergman CM, McGrath KM, Lingenheld EG, Grunnet ML, Padula SJ, Clark RB (1990) An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med 172:1193
117. Schiffenbauer J, Johnson HM, Butfiloski EJ, Wegrzyn L, Soos JM (1993) Stapylococcal enterotoxins can reactivate experimental allergic encephalomyelitis. Proc Natl Acad Sci USA 90:8543
118. Schlüsener H, Wekerle H (1985) Autoaggressive T lymphocyte lines recognize the encephalitogenic region of myelin basic protein; in vitro selection from unprimed rat T lymphocyte populations. J Immunol 135:3128
119. Schmied M, Breitschopf H, Gold R, Zischler H, Rothe G, Wekerle H, Lassmann H (1993) Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis: Evidence for programmed cell death as a mechanism to control inflammation in the brain. Amer. J Pathology 143:446
120. Selmaj K, Raine CS (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23:339
121. Selmaj K, Raine CS, Cross AH (1991) Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol 30:694
122. Semmler J, Wachtel H, Endres S (1993) The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells. Int J Immunopharmacol 15:409
123. + T cells. J Exp Med 180:2125
124. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K (1993) Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 11:729
125. Sharief MK, Hentges R (1991) Association between tumor necrosis factor-α and disease progression in chronic progressive multiple sclerosis. New Engl. J Med 325:467
126. Sharma SD, Nag B, Su XM, Spack E, Clark BR, Sriram S (1991) Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes. Proc Natl Acad Sci USA 88:11465
127. Smilek DE, Wraith DC, Hodgkinson S, Dwevedy S, Steinman L, McDevitt HO (1991) A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 88:9633
128. Sobel RA, Mitchell ME, Fondren G (1990) Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am J Path 136:1309
129. Sommer N, Löschmann P-A, Northoff GH, Weller M, Steinbrecher A, Steinbach JP, Lichtenfels R, Meyermann, R, Riethmüller A, Dichgans J, Martin R (1994) Tumor necrosis factor-directed therapy of autoimmune encephalomyelitis by the phosphodiesterase IV inhibitor rolipram. J Neuroimmunol 54:198
130. Sommer N, Löschmann P-A, Northoff GH, Weller M, Steinbrecher A, Steinbach JP, Lichtenfels R, Meyermann R, Riethmüller A, Dichgans J, Martin R (1995) Cytokine-directed suppression of autoimmune encephalomyelitis by the antidepressant rolipram. Nature Med 1:244
131. Steinman L, Rosenbaum J, Sriram S, McDevitt HO (1981) In vivo effects of antibodies to immune response gene products: Prevention of experimental allergic encephalomyelitis. Proc Natl Acad Sci USA 78:7111
132. Sun D, Qin Y, Chluba J, Epplen JT, Wekerle H (1988) Suppression of experimentally induced autoimmune encephalomyelitis by cytotoxic T-T cell interactions. Nature 332:843
133. Tabi Z, McCombe P, Pender MP (1994) Apoptotic elimination of Vβ8.2+ cells from the central nervous system during recovery from experimental autoimmune encephalomyelitis induced by the passive transfer of Vβ8.2+ encephalitogenic T cells. Eur J Immunol 24:2609
134. Tan LJ, Kennedy MK, Dal CM, Miller SD (1991) Successful treatment of paralytic relapses in adoptive experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance. J Immunol 147:1797
135. Tan LJ, Kennedy MK, Miller SD (1992) Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. II. Fine specificity of effector T cell inhibition. J Immunol 148:2748
136. Teitelbaum D, Aharoni R, Arnon R, Sela M (1988) Specific inhibition of the T-cell response to myelin basic protein by the synthetic copolymer Cop-1. Proc Natl Acad Sci USA 85:9724
137. Teitelbaum D, Meiner Z, Brenner T, Abramsky O, Kott E, Schlechter D, Gutman B, Nisipeanu P, Korczyn AD, Klein K, Fletcher S, Arnon R, Sela M (1994) Immunological parameters in a multicenter clinical trial of COP-1 in multiple sclerosis (MS): a 2 year follow-up. Neurology 44 [Suppl. 2]: A358
138. The IFNB Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43:655
139. Topham DJ, Nag B, Arimilli S, Sriram S (1994) A synthetic peptide from the third hypervariable region of major histocompatibility complex class II β chain as a vaccine for treatment of experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 91:8005
140. Tuohy VK, Lu Z, Sobel RA, Laursen RA, Lees MB (1988) A synthetic peptide from myelin proteolipid protein induces experimental allergic encephalomyelitis. J Immunol 141:1126
141. Urban JL, Kumar V, Kono DH, Gomez C, Horvath SJ, Clayton J, Ando DL, Sercarz EE, Hood L (1988) Restricted use of the T cells receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54:577
142. Utz U, Biddison WE, McFarland HF, McFarlin DE, Flerlage M, Martin R (1993) Skewed T cell receptor repertoire in genetically identical twins with multiple sclerosis correlates with disease. Nature 364:243
143. Utz U, Brooks JA, McFarland HF, Martin R, Biddison WE (1994) Heterogeneity of T-cell receptor α-chain complementarity-determining region 3 in myelin basic protein-specific T cells increases with severity of multiple sclerosis. Proc Natl Acad Sci USA 91:5567
144. Vandenbark AA, Hashim G, Offner H (1989) Immunization with a synthetic T-cell receptor V-region peptide against experimental autoimmune encephalomyelitis. Nature 341:541
145. Voskuhl RR, Martin R, Bergman C, Dalal M, Ruddle NH, McFarland HF (1993) T helper 1 (TH1) functional phenotype of human myelin basic protein-specific T lymphocytes. Autoimmunity 15:137
146. Waldor MK, Sriram S, Hardy R, Herzenberg LA, Herzenberg LA, Lanier L, Lim M, Steinman L (1985) Reversal of experimental allergic encephalomyelitis with a monoclonal antibody to a T cell subset marker (L3T4). Science 227:415
147. Watanabe R, Wege H, Meulen V ter (1983) Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis. Nature 305:150
148. Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson DM, Hafler DA (1993) Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259:1321
149. Wekerle H, Linington C, Lassmann H, Meyermann R (1986) Cellular immune reactivity within the CNS. Trends Neuro Sci 9:271
150. Welsh CT, Rose JW, Hill KE, Townsend JJ (1993) Augmentation of adoptively transferred experimental allergic encephalomyelitis by administration of a monoclonal antibody specific for LFA-1α. J Neuroimmunol 43:161
151. Welsh J, Sapatino B, Rosenbaum B, Smith R, Linthicum S (1993) Correlation between susceptibility to demyelination and interferon-γ induction of major histocompatibility complex class II antigens on murine cerebrovascular endothelial cells. J Neuroimmunol 48:91
152. Wilcox CE, Ward AMV, Evans A, Baker D, Rothlein R, Turk JL (1990) Endothelial cell expression of the intercellular adhesion molecule-1 (ICAM-1) in the central nervous system of guinea pigs during acute and chronic relapsing experimental allergic encephalomyelitis. J Neuroimmunol 30:43
153. Windhagen A, Scholz C, Fukaura H, Sette A, Hafler DA (1994) Switch of autoreactive human T cell clones from a Th2 to a TGFβ1 secreting phenotype with low affinity T-cell receptor stimulating peptide/MHC complex. J Neuroimmunol 54:206
154. Wong GHW, Bartlett PF, Clark-Lewis I, Battye F, Schrader JW (1984) Inducible expression of H-2 and Ia antigens on brain cells. Nature 310:688
155. Wong GHW, Clark-Lewis J, Harris AW, Schrader JW (1984) Effect of cloned interferon-γ on expression of H-2 and Ia antigen on cell lines of hemopoietic, lymphoid, epithelial, fibroblastic and neuronal origin. Eur J Immunol 14:52
156. Wraith DC, Smilek DE, Mitchell DJ, Steinman L, McDevitt HO (1989) Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell 59:247
157. Wucherpfennig KW, Ota K, Endo N, Seidman JG, Rosenzweig A, Weiner HL, Hafler DA (1990) Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein. Science 248:1016
158. Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N (1992) Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin. Nature 356:63
159. Yudkin PL, Ellison GW, Ghezzi A, Goodkin DE, Hughes RAC, McPherson K, Mertin J, Milanese C (1991) Overview of azathioprine in multiple sclerosis. Lancet 338:1051
160. Zaller DM, Osman G, Kanagawa O, Hood L (1990) Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor V beta-specific antibodies. J Exp Med 171:1943
161. Zamvil SS, Steinman E (1990) The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 8:579
162. Zhang J, Medaer R, Stinissen P, Hafler DA, Raus J (1993) MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science 261:1451
163. Zhang J, Markovic-Plese S, Lacet B, Raus J, Weiner HL, Hafler DA (1994) Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 179:973